ADAGE CAPITAL PARTNERS GP, L.L.C.

Q2 2022 13F-HR Detailed Holdings

Location
Boston, MA
Holdings as of
6/30/2022
Date filed
8/15/2022
Form type
13F-HR
Num holdings
1,075
Total value ($000)
$43,625,000
Net value change ($000)
-9,033,433 (-17.2%)
New positions
107
Sold out positions
109
Turnover %
8.5%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 5/16/2022 Next filing: 11/14/2022 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Biohaven Pharmaceutical Holding Co Ltd. 420,298 1865.7%
SVB FINANCIAL GROUP 101,649 104.9%
SNY 90,745 1497.9%
TWTR 88,145 272.8%
LLY 80,625 28.6%
BAH 75,637 NEW
HR 71,823 411.5%
KEY 62,489 429.5%
EL 61,473 NEW
DG 58,488 NEW
Top Reduces (Value $000, Stocks/ETFs)
AAPL -653,520 -23.1%
AMZN -522,850 -35.1%
MSFT -404,488 -16.6%
NVDA -308,718 -44.5%
RPRX -265,475 -27.4%
DLTR -242,354 -44.2%
TSLA -216,463 -27.5%
NTR -213,180 -100.0%
XOM -200,553 -25.5%
EYE -197,604 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None